Rust et al v. Johnson & Johnson et al
Nancy Rust and B. C. C. |
Johnson & Johnson, Janssen Pharmaceuticals Inc., Noramco, McKinsey & Company Inc. United States and West Virginia Board of Pharmacy |
3:2022cv01440 |
March 7, 2022 |
US District Court for the Northern District of California |
Charles R Breyer |
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. § 1332 Diversity-Personal Injury |
Plaintiff |
Docket Report
This docket was last retrieved on March 7, 2022. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 15 Case transferred in from District of West Virginia Southern; Case Number 5:21-cv-00449. Original file certified copy of transfer order and docket sheet received. |
MEMBER CASE OPENED: re 3:21-md-02996-CRB; Southern District of West Virginia, 5:21-cv-00449 Rust v. Johnson & Johnson, opened in California Northern District as 3:22-cv-01440-CRB pursuant to Conditional Transfer Order Transfer Order cc: JPMDL (wsn-adi, COURT STAFF) (Filed on 3/7/2022) |
Filing 14 TRANSFER ORDER, JUDICIAL PANEL ON MDL: certified copy from the Northern District of California transferring this action to the USDC/CAND for coordinated or consolidated pretrial proceedings. Signed by Karen K. Caldwell, Chair of the Panel on 3/3/2022. (cc: attys) (kew) |
Filing 13 TRANSFER ORDER FROM JUDICIAL PANEL ON MULTIDISTRICT LITIGATION re: MDL 2804 and MDL 2996. (kew) |
Filing 12 TRANSFER ORDER FROM JUDICIAL PANEL ON MULTIDISTRICT LITIGATION re: MDL 2804 and MDL 2996. (kew) |
Filing 11 NOTICE OF HEARING SESSION set for 12/2/2021 from the Judicial Panel on Multidistrict Litigation. (Original filed before the United States Judicial Panel on Multidistrict Litigation) (kew) |
Filing 10 ORDER re: #7 JOINT MOTION for an Immediate Stay of All Further Proceedings and Deadlines Pending Transfer of this Action to Multi District Litigation. This case is stayed and RETIRED to the inactive docket pending the MDL decision on a conditional transfer order. In the event the MDL panel decides not to file a conditional transfer order in the case, the parties are DIRECTED to inform the Court of such within 15 days of the MDL panel decision. Signed by Judge Frank W. Volk on 8/23/2021. (cc: counsel of record; any unrepresented party) (mk) |
Filing 9 STIPULATION EXTENDING TIME for West Virginia Board of Pharmacy to respond to Complaint by West Virginia Board of Pharmacy, Nancy Rust, B. C. C. (Taylor, Justin) (Modified on 8/19/2021 to add party filers) (mk). |
Filing 8 STIPULATION EXTENDING TIME for Johnson & Johnson and Janssen Pharmaceuticals, Inc. to respond to Complaint by Johnson & Johnson, Janssen Pharmaceuticals, Inc., Nancy Rust, B. C. C. (Williams, Marc) (Modified on 8/17/2021 to add party filers) (mk). |
Filing 7 JOINT MOTION by Johnson & Johnson, McKinsey & Company, Inc. United States, Janssen Pharmaceuticals, Inc. for an Immediate Stay of All Further Proceedings and Deadlines Pending Transfer of this Action to Multi District Litigation re: #1 Notice of Removal (Attachment: #1 Exhibit 1)(George, Keith) (Modified on 8/16/2021 to add party filer) (mk). |
Filing 6 STIPULATION EXTENDING TIME IN WHICH MCKINSEY MAY RESPOND TO COMPLAINT by Nancy Rust, B.C.C., McKinsey & Company, Inc. United States; said parties stipulate that the time within which McKinsey may move, answer or defend in any manner to the Complaint is extended to and including thirty (30) days after the later of (i) this Courts decision on any remand motion or (ii) the date that the Judicial Panel on Multidistrict Litigation ("JPML") sustains any valid objection to transfer of the claims against McKinsey in this Action to In re: McKinsey & Company, Inc. National Prescription Opiate Consultant Litigation, MDL No. 2996, pending in the United States District Court for the Northern District of California (the "McKinsey MDL"). (George, Keith) (Modified on 8/13/2021 to add party filers) |
Filing 5 DISCLOSURE STATEMENT PURSUANT TO RULE 7.1, Federal Rules of Civil Procedure, by Defendant McKinsey & Company, Inc. United States (George, Keith) |
Filing 4 DISCLOSURE STATEMENT PURSUANT TO RULE 7.1, Federal Rules of Civil Procedure, by Defendants Janssen Pharmaceuticals, Inc., Johnson & Johnson (Williams, Marc) |
Filing 3 AMENDED CERTIFICATE OF SERVICE by Janssen Pharmaceuticals, Inc., Johnson & Johnson for Notice of Removal. (Williams, Marc) |
Filing 2 STANDING ORDER IN RE: ASSIGNMENT AND REFERRAL OF CIVIL ACTIONS AND MATTERS TO MAGISTRATE JUDGES ENTERED JANUARY 4, 2016. Discovery referred to Magistrate Judge Aboulhosn. (cc: counsel of record; any unrepresented party) (btm) |
CASE assigned to Judge Frank W. Volk. (klc) |
Filing 1 NOTICE OF REMOVAL by Johnson & Johnson, Janssen Pharmaceuticals, Inc., McKinsey & Company, Inc. United States with complaint and docket sheet from Circuit Court of Greenbrier County. Filing Fee $402.00. Receipt #AWVSDC-8008893. (Attachments: #1 State Court Complaint, #2 State Court Docket Sheet, #3 Civil Cover Sheet) (btm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the California Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.